Embrace Change Acquisition Corp. Price & Performance (EMCGR)

Finnovate Acquisition Corp. has postponed its shareholder meeting to March 28, 2025, to finalize conditions for its business combination with Scage International. This marks the second delay as the company works on securing Nasdaq listing approval for Pubco's securities.1

DXI Capital Corp., along with V.V.T. Med Ltd. and Exiteam Acquisition Corp., received conditional approval for their reverse take-over transaction from the TSX Venture Exchange. The deal is expected to close within 45 days, pending final approvals, with trading anticipated to resume thereafter.2

Novolex has announced the pricing for its cash tender offer regarding Pactiv LLC’s 7.950% debentures due 2025. This move is part of Novolex's broader financial strategy, targeting specific debt instruments nearing maturity.3